Volume 109, Issue 4 , Pages 269-277, April 2010
Why is In-hospital Diagnosis of Pulmonary Tuberculosis Delayed in Southern Taiwan?
Article Outline
Background/Purpose
In-hospital diagnosis delay (IHDD) of pulmonary tuberculosis (TB) has a significant impact on nosocomial TB transmission. We investigated the risk factors associated with prolonged IHDD in Taiwan, a high-resource, mid-incidence area.
Methods
Between January 2005 and August 2006, we retrospectively enrolled 193 consecutive hospitalized patients. All of them had culture-proven pulmonary TB and did not receive antitubercular treatment at admission. IHDD was defined as the interval between admission and initiation of antitubercular treatment. Patients were grouped according to the median value of IHDD.
Results
The median IHDD was 7 days. Patients with IHDD > 7 days were considered the prolonged-delay group, and those with IHDD £ 7 days, the short-delay group. Independent risk factors [with adjusted odd ratios (95% confidence intervals)] for prolonged IHDD were: negative sputum smear [47.53 (13.20–171.18), p < 0.001]; non-cavitary lesions on chest radiographs [14.90 (3.46–64.14), p < 0.001]; admission to hospital departments other than chest medicine/infectious diseases [6.60 (1.95–22.41), p = 0.002]; exposure to fluoroquinolones before antitubercular treatment [5.29 (1.13–24.75), p = 0.034]; underlying malignancy [4.59 (1.13–18.67), p = 0.033); and age > 65 years [3.19 (1.01–10.05), p = 0.048]. Death attributed to tuberculosis was associated with positive sputum smear (hazard ratio = 21.85; 95% CI = 2.74–174.44; p = 0.004) but not prolonged IHDD (p = 0.325).
Conclusion
To minimize IHDD, clinicians should carefully manage hospitalized patients with risk factors for prolonged delay, such as those with negative sputum smears, non-cavitary lesions on chest radiographs, admission to departments other than chest medicine/infectious diseases, exposure to fluoroquinolones before antitubercular treatment, underlying malignancy, and age > 65 years.
Key Words: delayed diagnosis , fluoroquinolones , malignancy , risk factors , tuberculosis
No full text is available. To read the body of this article, please view the PDF online.
References
- Spread of Mycobacterium tuberculosis in a community implementing recommended elements of tuberculosis control . JAMA . 2000;283:2968–2974
- Determinants of health system delay among confirmed tuberculosis cases in Spain . Eur J Public Health . 2005;15:343–349
- Patient and health system delays in the diagnosis and treatment of tuberculosis in Southern Taiwan . Int J Tuberc Lung Dis . 2005;9:1006–1012
- Delay in diagnosis among hospitalized patients with active tuberculosis—predictors and outcomes . Am J Respir Crit Care Med . 2002;165:927–933
- Intervals before tuberculosis diagnosis and isolation at a regional hospital in Taiwan . J Formos Med Assoc . 2007;106:1007–1012
- Validity of clinical prediction rules for isolating inpatients with suspected tuberculosis. A systematic review . J Gen Intern Med . 2005;20:947–952
- Tuberculosis in health care workers during declining tuberculosis incidence in New York State . Am J Infect Control . 2005;33:519–526
- Tuberculosis among health care workers . N Engl J Med . 1995;332:92–98
- Delays in the diagnosis and treatment of hospitalized patients with smear-positive pulmonary tuberculosis . Respir Med . 2001;95:802–805
- Tuberculosis among health care workers in a short working period . Am J Infect Control . 2005;33:23–26
- Risk of tuberculosis among healthcare workers: can tuberculosis be considered as an occupational disease? . Respir Med . 2002;96:506–510
- . Healthcare workers with tuberculosis infected during work . Eur Respir J . 2006;28:1216–1221
- Centers for Disease Control, Department of Health, Executive Yuan, Taiwan, R.O.C. Statistics of Communicable Diseases and Surveillance Report, Republic of China, 2005. 2006:144–8.
- The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis: derivation of a pulmonary tuberculosis prediction model . Chest . 1999;115:1248–1253
- Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas . Thorax . 2006;61:903–908
- Delays in the suspicion and treatment of tuberculosis among hospitalized patients . Ann Intern Med . 1999;130:404–411
- Delayed tuberculosis diagnosis and tuberculosis transmission . Int J Tuberc Lung Dis . 2006;10:24–30
- . Trends in mortality from tuberculosis in England and Wales: effect of age on deaths from non-respiratory disease . Thorax . 1995;50:976–979
- Delayed diagnosis of pulmonary tuberculosis in city hospitals . Arch Intern Med . 1994;154:306–310
- Risk factors for treatment delay in pulmonary tuberculosis in Recife, Brazil . BMC Public Health . 2005;5:25
- . Tuberculosis and aging: a global health problem . Clin Infect Dis . 2001;33:1034–1039
- . Patient and health service delay in the diagnosis of pulmonary tuberculosis in Ethiopia . BMC Public Health . 2002;2:23
- Patient and health care system delays in the diagnosis and treatment of tuberculosis . Int J Tuberc Lung Dis . 1999;3:1088–1095
- . Early identification and isolation of inpatients at high risk for tuberculosis . Arch Intern Med . 1994;154:326–330
- Factors associated with a clinician's decision to stop anti-tuberculosis treatment before completion . Int J Tuberc Lung Dis . 2008;12:441–446
- Impact of empiric antibiotics and chest radiograph on delays in the diagnosis of tuberculosis . Int J Tuberc Lung Dis . 2005;9:392–397
- Association between physician caseload and patient outcome for sepsis treatment . Infect Control Hosp Epidemiol . 2009;30:556–562
- . Does the use of fluoroquinolones for the empiric treatment of pneumonia delay initiation of treatment of tuberculosis? . Clin Infect Dis . 2002;35:1572–1573
- Impact of short-term exposure to fluoroquinolones on ofloxacin resistance in HIV-negative patients with tuberculosis . Int J Tuberc Lung Dis . 2007;11:319–324
- . Tuberculosis mortality in notified cases from 1989–1995 in Birmingham . Public Health . 1998;112:165–168
- The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis . Chest . 1998;114:1244–1252
- Outcome of multidrug-resistant tuberculosis in human immunodeficiency virus-infected patients . Clin Infect Dis . 1999;29:553–560
- . Patient and health service delay in pulmonary tuberculosis patients attending a referral hospital: a cross-sectional study . BMC Public Health . 2005;5:122
- Delay in the diagnosis of pulmonary tuberculosis, London, 1998–2000: analysis of surveillance data . BMJ . 2003;326:909–910
- . Risk factors for death among tuberculosis cases: analysis of European surveillance data . Eur Respir J . 2008;31:1256–1260
PII: S0929-6646(10)60052-6
doi:10.1016/S0929-6646(10)60052-6
© 2010 Formosan Medical Association & Elsevier. Published by Elsevier Inc. All rights reserved.
Volume 109, Issue 4 , Pages 269-277, April 2010
